Literature DB >> 33034777

Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies.

Mateus Grings1, Moacir Wajner1,2,3, Guilhian Leipnitz4,5.   

Abstract

Ethylmalonic encephalopathy (EE) is a severe intoxication disorder caused by mutations in the ETHE1 gene that encodes a mitochondrial sulfur dioxygenase involved in the catabolism of hydrogen sulfide. It is biochemically characterized by tissue accumulation of hydrogen sulfide and its by-product thiosulfate, as well as of ethylmalonic acid due to hydrogen sulfide-induced inhibition of short-chain acyl-CoA dehydrogenase. Patients usually present with early onset severe brain damage associated to encephalopathy, chronic hemorrhagic diarrhea and vascular lesions with petechial purpura and orthostatic acrocyanosis whose pathophysiology is poorly known. Current treatment aims to reduce hydrogen sulfide accumulation, but does not significantly prevent encephalopathy and most fatalities. In this review, we will summarize the present knowledge obtained from human and animal studies showing that disruption of mitochondrial and redox homeostasis may represent relevant pathomechanisms of tissue damage in EE. Mounting evidence show that hydrogen sulfide and ethylmalonic acid markedly disturb critical mitochondrial functions and induce oxidative stress. Novel therapeutic strategies using promising candidate drugs for this devastating disease are also discussed.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Brain damage; Ethylmalonic acid; Ethylmalonic encephalopathy; Hydrogen sulfide; Mitochondria; Redox homeostasis

Mesh:

Substances:

Year:  2020        PMID: 33034777     DOI: 10.1007/s10571-020-00976-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  79 in total

1.  New clinical phenotype of branched-chain acyl-CoA oxidation defect.

Authors:  A Burlina; F Zacchello; C Dionisi-Vici; E Bertini; G Sabetta; M J Bennet; D E Hale; E Schmidt-Sommerfeld; P Rinaldo
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

2.  A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Authors:  Xu Cao; Lei Ding; Zhi-Zhong Xie; Yong Yang; Matthew Whiteman; Philip K Moore; Jin-Song Bian
Journal:  Antioxid Redox Signal       Date:  2018-06-29       Impact factor: 8.401

Review 3.  Mitochondrially-targeted treatment strategies.

Authors:  Luiz H M Bozi; Juliane C Campos; Vanessa O Zambelli; Nikolas D Ferreira; Julio C B Ferreira
Journal:  Mol Aspects Med       Date:  2019-12-19

Review 4.  Neurological disorders and mitochondria.

Authors:  J V Cabral-Costa; A J Kowaltowski
Journal:  Mol Aspects Med       Date:  2019-10-17

Review 5.  Mitochondria as multifaceted regulators of cell death.

Authors:  Florian J Bock; Stephen W G Tait
Journal:  Nat Rev Mol Cell Biol       Date:  2019-10-21       Impact factor: 94.444

6.  Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy.

Authors:  M Boyer; M Sowa; I Di Meo; S Eftekharian; M R Steenari; V Tiranti; J E Abdenur
Journal:  Mol Genet Metab       Date:  2018-02-14       Impact factor: 4.797

7.  Ethylmalonic acid impairs brain mitochondrial succinate and malate transport.

Authors:  Alexandre Umpierrez Amaral; Cristiane Cecatto; Estela Natasha Brandt Busanello; César Augusto João Ribeiro; Daniela Rodrigues Melo; Guilhian Leipnitz; Roger Frigério Castilho; Moacir Wajner
Journal:  Mol Genet Metab       Date:  2011-10-19       Impact factor: 4.797

8.  Ethylmalonic acid induces permeability transition in isolated brain mitochondria.

Authors:  Cristiane Cecatto; Alexandre Umpierrez Amaral; Guilhian Leipnitz; Roger Frigério Castilho; Moacir Wajner
Journal:  Neurotox Res       Date:  2014-02-21       Impact factor: 3.911

9.  Diffusion restriction in ethylmalonic encephalopathy - An imaging evidence of the pathophysiology of the disease.

Authors:  Maya Dattatraya Bhat; Chandrajit Prasad; Sarbesh Tiwari; Sadanandavalli Retnaswami Chandra; Rita Christopher
Journal:  Brain Dev       Date:  2016-03-15       Impact factor: 1.961

10.  A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts.

Authors:  A B Burlina; C Dionisi-Vici; M J Bennett; K M Gibson; S Servidei; E Bertini; D E Hale; E Schmidt-Sommerfeld; G Sabetta; F Zacchello
Journal:  J Pediatr       Date:  1994-01       Impact factor: 4.406

View more
  1 in total

Review 1.  Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders.

Authors:  Bianca Seminotti; Mateus Grings; Paolo Tucci; Guilhian Leipnitz; Luciano Saso
Journal:  Front Cell Neurosci       Date:  2021-11-26       Impact factor: 5.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.